Characterization of chronic fatigue in patients with sarcoidosis in clinical remission

Chest

Volumn 140, Issue 2, 2011, Pages 441-447

  Korenromp, Ingrid H E ^a,b   Heijnen, Cobi J ^b   Vogels, Oscar J M ^a   Van Den Bosch, Jules M M ^a,b   Grutters, Jan C ^a,b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CHECKLIST INDIVIDUAL STRENGTH; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; GRIP STRENGTH; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUESTIONNAIRE; REMISSION; SARCOIDOSIS; SHORT FORM 36; SLEEP QUALITY; SYMPTOM CHECKLIST 90;

EID: 80051501233     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2629     Document Type: Article

References (38)

1. Wirnsberger RM, de Vries J, Breteler MH, van Heck GL, Wouters EF, Drent M. Evaluation of quality of life in sarcoidosis patients. Respir Med. 1998;92(5):750-756. (Pubitemid 28279449)
2. Wirnsberger RM, de Vries J, Wouters EF, Drent M. Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. Neth J Med. 1998;53(2):53-60. (Pubitemid 28394069)
3. Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J. Fatigue is associated with quality of life in sarcoidosis patients. Chest. 2006;130(4):989-994. (Pubitemid 44583726)
4. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest. 2007;132(1):207-213. (Pubitemid 47068223)
5. De Vries J, Drent M. Quality of life and health status in sarcoidosis: a review of the literature. Clin Chest Med. 2008;29(3):525-532. (Pubitemid 351778213)
6. de Kleijn WP, De Vries J, Lower EE, Elfferich MD, Baughman RP, Drent M. Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med. 2009;15(5):499-506.
7. James DG. Complications of sarcoidosis. Chronic fatigue syndrome. Sarcoidosis. 1993;10(1):1-3.
8. Sharma OP. Fatigue and sarcoidosis. Eur Respir J. 1999;13(4):713-714. (Pubitemid 29234765)
9. Drent M, De Vries J, Demedts MG. Sarcoidosis and fatigue. Neth J Med. 2002;58(19):1261-1268.
10. Drent M. Sarcoidosis and fatigue. Mod Med. 2003;27(11):830-835.
11. Minderhoud IM, Oldenburg B, van Dam PS, van Berge Henegouwen GP. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol. 2003;98(5):1088-1093. (Pubitemid 36733771)
12. Pollard L, Choy EH, Scott DL. The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol. 2005;23(5 suppl 39):S43-S52. (Pubitemid 46657510)
13. Candy B, Chalder T, Cleare AJ, Wessely S, White PD, Hotopf M. Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review. Br J Gen Pract.2002;52(483):844-851.
14. Gielissen MF, Schattenberg AV, Verhagen CA, Rinkes MJ, Bremmers ME, Bleijenberg G. Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant. 2007;39(10):595-603. (Pubitemid 46722841)
15. Servaes P, Gielissen MF, Verhagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology. 2007;16(9):787-795. (Pubitemid 47456237)
16. Ayres JG, Flint N, Smith EG, et al. Post-infection fatigue syndrome following Q fever. QJM. 1998;91(2):105-123. (Pubitemid 28102664)
17. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A; International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953-959. (Pubitemid 24370860)
18. Costabel U, Hunninghake GW; Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. ATS/ERS/WASOG statement on sarcoidosis. Eur Respir J. 1999;14(4):735-737.
19. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet. 2006;367(9507):346-355. (Pubitemid 43151468)
20. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383-392. (Pubitemid 24188056)
21. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.
22. Van der Zee KI, Sanderman R. SF-36, Manual Dutch version [in Dutch]. Groningen, The Netherlands: Noordelijk Centrum voor Gezondheidsvraagstukken; 1993.
23. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997;35(8):785-791. (Pubitemid 27336913)
24. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull. 1973;9(1):13-28.
25. Arrindell WA, Ettema JHM. Dutch Manual SCL-90 [in Dutch]. Amsterdam, The Netherlands: Hartcourt Test Publishers; 1986.
26. van der Werf SP, Prins JB, Vercoulen JH, van der Meer JW, Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res. 2000;49(5):373-379. (Pubitemid 32123814)
27. Vercoulen JH, Hommes OR, Swanink CM, et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol. 1996;53(7):642-649. (Pubitemid 26242214)
28. Servaes P, van der Werf S, Prins J, Verhagen S, Bleijenberg G. Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer. 2001;9(1):11-17. (Pubitemid 32125584)
29. Hickie I, Davenport T, Wakefield D, et al Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575.
30. Koschera A, Hickie I, Hadzi-Pavlovic D, Wilson A, Lloyd A. Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample. Aust N Z J Psychiatry.1999;33(4):545-552. (Pubitemid 29386877)
31. White PD, Thomas JM, Kangro HO, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet. 2001;358(9297):1946-1954. (Pubitemid 34072876)
32. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. (Pubitemid 350295688)
33. Blackwood SK, MacHale SM, Power MJ, Goodwin GM, Lawrie SM. Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. J Neurol Neurosurg Psychiatry. 1998;65(4):541-546. (Pubitemid 28438888)
34. Spruit MA, Thomeer MJ, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax. 2005;60(1):32-38. (Pubitemid 40101015)
35. Consensus conference. Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J. 1994;7(3):624-627.
36. Costabel U, Ohshimo S, Guzman J. Diagnosis of sarcoidosis. Curr Opin Pulm Med. 2008;14(5):455-461.
37. 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis. Eur J Nucl Med Mol Imaging. 2009;36(7): 1131- 1137.
38. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29(2):247-264.